Biological approaches of termite management: A review

For increased crop production, the role of chemical termiticides cannot be neglected as they have provided the efficient way to achieve green revolution. But the present scenario has forced mankind to search for alternative options. While keeping in mind the concept of sustainable agriculture, pest management including termites and other phyto-diseases etc. needs to be focused. For the achievement of the above stated goal, eco-friendly and cost-effective strategies need to be emphasized. Biopesticidal agents that mainly comprise of herbal and microbial formulations are known to exhibit anti termite activity and have a pivotal role in the production of organic food products. In order to reduce the chemical consumption, the vast area of biological alternatives needs to be explored as they provide us with many beneficial aspects like sustainability, suitable application, biodegradable nature, target specificity etc. Further, the bioactive components of such biological agents can later be used as commercially viable termiticides in the form of formulations. These herbal and microbial termiticides are effective and have immense scope to be used in future for sustainable development

Innovative investigation of zinc oxide nanoparticles used in dentistry

Dental caries is a major lifestyle concern as dental components affect the face of an individual. The issue of tooth decay occurs in every age group throughout the globe. Researchers are probing incipient implements and techniques to develop filling agents for decayed teeth. Zinc oxide (ZnO) powder is utilized mostly as a filling agent. Nanotechnology enhanced the efficiency of compounds of metal oxides utilized for dental caries. The present study aims to investigate the properties of ZnO nanoparticles (NPs) synthesized chemically (using ZnCl2 and NaOH) as well as biologically (using aqueous leaf extract of Murraya paniculata). The XRD patterns confirm that ZnO NPs have a hexagonal crystalline structure with particle sizes of 47 nm and 55 nm for chemically and biologically synthesized NPs, respectively. The FE-SEM data confirm the nanorod and spherical/cubical shape morphologies for the chemically and biologically synthesized ZnO NPs, respectively. FTIR data show the peaks between 4000 and 450 cm(-1) of the functional groups of -OH, C-O, -C-H-, and Zn-O bonds. The UV-Vis absorption study indicates a peak around 370 nm and a hump around 360 nm corresponding to the chemically and biologically synthesized ZnO NPs, respectively. An antibacterial bioassay was performed and compared with commercially available ZnO bulk powder against tooth decaying pathogens, viz., Streptococcus mutans, Staphylococcus aureus, E. coli, and Lactobacillus fermentum, and found that both ZnO NPs had results closer to those of the standard drug (rifampicin). Thus, the synthesized ZnO NPs may be utilized as nano-drugs for the application of tooth decaying filling agents. Even biologically synthesized ZnO NPs may be considered more environmentally friendly and less toxic to human health concerns.UGC, New DelhiUniversity Grants Commission, UGC; University of Lucknow, L

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

Peripheral T cell lymphomas are typically aggressive with a poor prognosis. Unlike other hematologic malignancies, the lack of target antigens to discriminate healthy from malignant cells limits the efficacy of immunotherapeutic approaches. The T cell receptor expresses one of two highly homologous chains [T cell receptor β-chain constant (TRBC) domains 1 and 2] in a mutually exclusive manner, making it a promising target. Here we demonstrate specificity redirection by rational design using structure-guided computational biology to generate a TRBC2-specific antibody (KFN), complementing the antibody previously described by our laboratory with unique TRBC1 specificity (Jovi-1) in targeting broader spectrum of T cell malignancies clonally expressing either of the two chains. This permits generation of paired reagents (chimeric antigen receptor-T cells) specific for TRBC1 and TRBC2, with preclinical evidence to support their efficacy in T cell malignancies

NACA2412 airfoil based method for design and aerodynamic analysis of small HAWT using modified BEM approach

Efficient utilization of wind energy depends on careful selection and suitable design of Wind Turbine (WT) blades. Small scale Wind Turbines (SWT) normally operate in the low range of Angle of Attack (AoA). This makes the task even more difficult for designing and optimization of WT blades. This article deals with an airfoil based computational approach to design the blade for a standalone small scale Horizontal Axis Wind Turbine (HAWT). A procedure has been proposed to find the important parameters and analyze the performance characteristics for a three bladed HAWT operating under the wake rotation. Computational code has been written to find optimum blade profile. Twist angle variation, chord length and other related parameters are determined with the help of program. Comparison between different types of airfoil has been made to figure out the most suitable one. Airfoil selection and design approach are intended to make Wind Turbine blade efficient specially under low range of AoA. Characteristics of the Wind Turbine obtained analytically from this procedure are compared with several other reported earlier in some of the literatures. The result obtained by the proposed procedure is simpler and more efficient than BEM theory – a method normally employed for blade design

A case of bullous systemic lupus erythematosus: Diagnostic challenges and clinical implications

Key Clinical Message Skin involvement in systemic lupus erythematosus (SLE) is common. Bullous lesions in SLE patients are usually due to other autoimmune conditions or rarely, due to lupus itself. Bullous SLE is rare blistering disorder characterized by subepidermal blisters. We, hereby, present a case of bullous SLE in a 24‐year‐old female who responded well to systemic glucocorticoids, mycophenolate mofetil, and dapsone